Brought to you by:
VAM 2025 abstract submission period set to open Nov. 6
Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June starting from Nov. 6 through Wednesday, Jan. 8, 2025. VAM research—both clinical and translational—is considered for presentation in several different forums that appeal…
Former SVS president named ACS president-elect
The American College of Surgeons (ACS) elected Anton N. Sidawy, MD, as president-elect during the ACS annual business meeting on Oct. 22. He served as president of the Society for Vascular Surgery (SVS) in 2010. Sidawy is currently the Lewis…
Surmodics announces early results from PROWL registry of Pounce thrombectomy system
Surmodics has announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischaemia patients from its PROWL registry study were presented by Dean Ferrera (Powers Health, Munster, USA) at TCT 2024 (27–30 October, Washington, DC,…
The Japanese concept of ikigai and how mentorship might help specialty amid challenges of vascular surgery workforce shortage
The Japanese concept of ikigai, or an individual’s reason for being, underpinned the message behind a fresh call for mentorship in vascular surgery and how mentoring could aid efforts to plug a shortage in the specialty’s workforce. Roy M. Fujitani,…
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) found that LBMT is superior with respect to the hierarchically-tested aggregated…
TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel DCB
Data from the prospective, multicentre, investigator-initiated SIRONA randomised clinical trial demonstrated MagicTouch (Concept Medical) sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety and efficacy endpoints in patients with femoropopliteal artery disease. Findings were…
NESVS 2024: Simons becomes first woman president of New England Society for Vascular Surgery
Jessica P. Simons, MD, has become the 2024–25 president of the New England Society for Vascular Surgery (NESVS). She is the first woman to serve as NESVS president since the society was formed in 1973. She assumed the role at…
TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system
Vivasure Medical has announced initial positive results from its US IDE PATCH pivotal study evaluating the safety and efficacy of the Vivasure PerQseal closure device system. Results were presented at TCT 2024 (27–30 October, Washington, DC, USA) PerQseal is the…
Thrombolex begins enrolment in RAPID-PE study of Bashir catheter
Thrombolex has announced the enrolment of the first two patients in the RAPID-PE study using the Bashir endovascular catheter for the treatment of acute pulmonary embolism (PE). The patients were enrolled by Ayman Iskander (St Joseph’s Health Hospital, Syracuse, USA).…
SVS launches Highway to Health campaign to help people maintain vascular health at every age
According to a new national survey released by the Society for Vascular Surgery (SVS), nearly one in three Americans at the highest risk for developing vascular diseases have not heard of any of the most common conditions, like peripheral arterial disease…